seed
Stage
1
Investors
About
Circe Bioscience uses a proprietary aerobic gas fermentation process to convert CO2 into industry-agnostic, high-value chemical molecules, enabling carbon-negative manufacturing for food, chemical, and fuel industries.
Explore Circe Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.